Fluvoxamine for COVID-19: A New Weapon in the Fight?

The antidepressant appears to have some ability to prevent worsening in outpatients with COVID-19

By virtually all metrics, vaccine development for COVID-19 has been an astonishing success. But when it comes to therapeutics, the picture is much more mixed. This means the tip of the spear of the battle against…